2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Mini-Oral Session

[MO3] Mini-Oral Session 3 Gastrointestinal Cancer 1(Upper GI Tract 1)
【E】

Thu. Feb 17, 2022 1:20 PM - 2:10 PM Room 5 (Room B-1, 2F, Kyoto International Conference Center)

Chair:Daisuke Takahari(Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital of Japanese Foundation For Cancer Research),Shuichi Hironaka(Medical Oncology, Saitama Medical University International Medical Center)

Takashi Ohta1, Sachiko Yamamoto2, Takayuki Kii3, Hiroki Hara4, Ryohei Kawabata5,6, Junji Kawada7, Atsushi Takeno8, Jin Matsuyama9, Shugo Ueda10, Hisato Kawakami11, Yoshihiro Okita12,13, Shunji Endo14, Yutaka Kimura6,15, Kazuhiro Yanagihara16, Tatsuya Okuno17, Yukinori Kurokawa18, Toshio Shimokawa19, Taroh Satoh20 (1.Department of Clinical Oncology / Department of Gastroenterology, Kansai Rosai Hospital, 2.Department of Gastrointestinal Oncology, Osaka International Cancer Institute, 3.Cancer Chemotherapy Center, Osaka Medical and Pharmaceutical University, 4.Department of Gastroenterology, Saitama Cancer Center, 5.Department of Surgery, Osaka Rosai Hospital, 6.Department of Surgery, Sakai City Medical Center, 7.Department of Surgery, Osaka General Medical Center, 8.Department of Surgery, Kansai Rosai Hospital, 9.Department of Surgery, Yao Municipal Hospital, 10.Department of Gastroenterological Surgery and Oncology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, 11.Department of Medical Oncology, Kindai University Faculty of Medicine, 12.Department of Medical Oncology, Kobe City Medical Center General Hospital, 13.Department of Clinical Oncology, Kagawa University Faculty of Medicine, 14.Department of Gastroenterological Surgery, Higashiosaka City Medical Center, 15.Department of Surgery, Kindai University Faculty of Medicine, 16.Department of Medical Oncology, Kansai Electric Power Hospital, 17.Division of Gastroenterology, Department of Internal Medicine, Graduate School of Medicine, Kobe University, 18.Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, 19.Department of Medical Data Science, Graduate School of Medicine, Wakayama Medical University, 20.Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine)

Mao Okada2, Shun Yamamoto2, Akihiro Ohara2, Mai Itoyama2, Yoshitaka Honma2, Tairo Kashihara3, Koji Inaba3, Koshiro Ishiyama4, Junya Oguma4, Hiroshi Igaki3, Hiroyuki Daiko4, Ken Kato2 (1.National Cancer Center Hospital, 2.Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, 3.Department of Radiation Oncology, National Cancer Center Hospital, 4.Department of Esophageal Surgery, National Cancer Center Hospital)

Ryosuke Kumanishi1, Takatsugu Ogata1, Takumi Habu2, Hideaki Bando3, Takeshi Fujisawa4, Shogo Kumagai2, Hisashi Fujiwara5, Saori Mishima3, Daisuke Kotani3, Masaki Nakamura4, Hidehiro Hojo4, Shohei Koyama2, Hiroyoshi Nishikawa2, Tomonori Yano6, Takeo Fujita5, Shigenori Kadowaki1, Takahiro Kinoshita7, Masahiro Tajika8, Kei Muro1, Takashi Kojima3 (1.Department of Clinical Oncology, Aichi Cancer Center Hospital, 2.Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Kashiwa, Japan, 3.Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan, 4.Division of Radiation Oncology and Particle Therapy, National Cancer Center Hospital East, Kashiwa, Japan, 5.Division of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Japan, 6.Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan, 7.Department of Surgical Oncology, National Cancer Center Hospital East, Kashiwa, Japan, 8.Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan)

Keitaro Shimozaki1,2, Izuma Nakayama1, Daisuke Takahari1, Hiroki Osumi1, Takeru Wakatsuki1, Akira Oki1, Mariko Ogura1, Eiji Shinozaki1, Keisho Chin1, Kensei Yamaguchi1 (1.Department of Gastroenterological chemotherapy, Cancer Institute Hospital of JFCR, 2.Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine)

Kazuhiro Shiraishi1, Toshiko Masuishi2, Takatsugu Ogata2, Kyoko Kato1, Keiji Sugiyama1, Natsuki Nishikawa3, Chiho Kudo4, Natsumi Takayanagi4, Yukiya Narita2, Hiroaki Uda5, Shigenori Kadowaki2, Masashi Ando2, Chiyoe Kitagawa1, Masato Kataoka5, Kei Muro2 (1.Department of Medical Oncology, National Hospital Organization Nagoya Medical Center, 2.Department of Clinical Oncology, Aichi Cancer Center Hospital, 3.Division of Clinical Research Coordination, National Hospital Organization Nagoya Medical Center, 4.Department of Clinical Research Support Office, Aichi Cancer Cetnter Hospital, 5.Department of Surgery, National Hospital Organization Nagoya Medical Center)

Hirokazu Shoji1, Daisuke Takahari2, Keiko Minashi3, Hiroki Hara4, Keisho Chin2, Akira Ooki2, Mariko Ogura2, Izuma Nakayama2, Ken Kato1, Satoru Iwasa1, Hidekazu Hirano1, Yusuke Amanuma3, Naoki Ishizuka5, Narikazu Boku1, Kensei Yamaguchi2 (1.Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 2.Department of Gastroenterology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3.Clinical Trial Promotion Department, Chiba Cancer Center, 4.Department of Gastroenterology, Saitama Cancer Center, 5.Department of Clinical Trial Planning and Management, Cancer Institute Hospital of Japanese Foundation for Cancer Research)